The Seattle HVTU, led by Principle Investigator, Julie McElrath, is one of the 10 U.S. clinical trials units within the HIV Vaccine Trials Network (HVTN). This network is funded to conduct phase I, II, and III clinical trials designed to test the safety and efficacy of HIV Vaccines. Located on Capital Hill, the HVTU is a joint research program between the FHCRC and the University of Washington.
Since 1987, the Seattle HVTU has worked with local community members who are interested in participating in HIV Vaccine clinical trials and has provided HIV education to the local community. As a clinical trial unit, the HVTU is responsible for the recruitment, selection, and enrollment of local volunteers, immunization and clinical monitoring of the clinical trial participants, and manages follow-up care for trial participants. As a part of the HVTN, the Seattle HVTU is also involved in the design of the clinical protocols for the HIV vaccine trials.
For more information about the HVTU and how to participate in HIV Vaccine Trials, see Seattle HVTU’s website at http://seattlevaccines.org